Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00167375 · ClinicalTrials.gov registry record
Testing the Nocturnal Sleep Latency Profile in Primary Insomnia
A clinical trial of Sleep Initiation and Maintenance Disorders and Primary Insomnia, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 24
- Enrollment target
- 1
- Study location
NCT00167375: Completed study of Sleep Initiation and Maintenance Disorders and Primary Insomnia, sponsored by University of Pittsburgh.
NCT00167375 is a study of Sleep Initiation and Maintenance Disorders and Primary Insomnia that has completed, run by University of Pittsburgh. The registered enrollment target is 24 participants, below the 289-participant average among 19 other Sleep Initiation and Maintenance Disorders trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00167375, a study of Sleep Initiation and Maintenance Disorders and Primary Insomnia, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This study tests a new kind of sleep study in which subjects are awakened 2 times after initially going to sleep. The study focuses on the EEG signal process as a person goes to sleep. The general hypothesis is that the signal properties are stable from night to night during baseline studies, and are different between controls and patients with primary insomnia. The primary insomnia patients then go on to have about 2 weeks of an insomnia intervention. Then the new kind of study is repeated in the patients. The controls only are examined in baseline studies.
Conditions Studied
Interventions
- DRUG eszopiclone 3 mg qHS
- BEHAVIORAL General cognitive/behavioral interventions for insomnia
Study Locations (1)
Pennsylvania
- Western Psychiatric Institute and Clinic - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2005-01 |
| Est. Completion | 2007-06 |
What the finished NCT00167375 record still lists
NCT00167375 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 289-participant average among 19 other Sleep Initiation and Maintenance Disorders trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Sleep Initiation and Maintenance Disorders appearing as the primary indexed condition, and to 2 interventions - of which eszopiclone 3 mg qHS is the first listed.
NCT00167375 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00167375 about?
NCT00167375 is a clinical study titled "Testing the Nocturnal Sleep Latency Profile in Primary Insomnia". This study tests a new kind of sleep study in which subjects are awakened 2 times after initially going to sleep. The study focuses on the EEG signal process as a person goes to sleep. The general hypothesis is that the signal properties are stable from night to night during baseline studies, and ar...
What is the current status of trial NCT00167375?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2005-01. Estimated completion is 2007-06.
What conditions does trial NCT00167375 study?
This clinical trial studies the following conditions: Sleep Initiation and Maintenance Disorders, Primary Insomnia.
What interventions are being tested in trial NCT00167375?
The interventions under investigation include: eszopiclone 3 mg qHS (DRUG), General cognitive/behavioral interventions for insomnia (BEHAVIORAL).
Who is sponsoring clinical trial NCT00167375?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00167375 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Initiation and Maintenance Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00167375's enrollment target sits among peer trials
24 19th of 19 the lowest of 19 other Sleep Initiation and Maintenance Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep Initiation and Maintenance Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindfulness Meditation for Insomnia
RECRUITING · Phase 1
-
Optimizing Sleep Health in Nurses
RECRUITING · NA
-
Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)
RECRUITING · Phase 2
-
Sleep for Health Study on the Effects of Cognitive Behavioral Therapy for Insomnia on Diabetes Risk
RECRUITING · NA
-
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
RECRUITING · Phase 4
-
A Study to Assess the Pregnancy Outcome in Women Exposed to Dayvigo® During Pregnancy Compared to an Unexposed Control Population
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia